Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Applying LC-MS/MS techniques to the development of biologics

4 May 2018
General interest

PPD® Laboratories’ Unique Approach to Biologics
For three decades, PPD Laboratories has been developing and validating bioanalytical assays for all
phases of pharmaceutical development across a wide variety

Please click here to download PPD Laboratories tech sheet on applying LC-MS/MS techniques to the development of biologics.

 

Top content

  • Major M&A deals impacting bioanalysis in 2026
  • Merck snaps up Terns Pharmaceuticals to expand its oncology pipeline
  • Ask the Experts: quantifying translational biomarkers

Related tags

LC-MS LC–MS/MS pharmaceuticals PPD quantification
Previous article Next article

Related articles

7 AUG 2012 EXPERT OPINION
Is the bioanalytical community ready to revise the use of certain validation concepts and nomenclature? 
11 MAR 2015 CHROMATOGRAPHY
Quantitation of 25-hydroxyvitamin D2 and D3 in serum and plasma by LCMS/MS
20 MAR 2026 NEWS
Six plasma metabolites show association with hip fracture risk
30 APR 2010 CHROMATOGRAPHY
Analytical methodologies utilized in the search for chronic disease biomarkers
23 MAY 2011 CHROMATOGRAPHY
Current strategies in the discovery of small-molecule biomarkers for Alzheimer’s disease
20 DEC 2012 DATA PROCESSING AND INTERPRETATION
Development and validation of an ultra-sensitive method for the measurement of plasma renin activity in human plasma via LC–MS/MS
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone